Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 21, 2023; 29(3): 450-468
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.450
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.450
Table 6 Generic names and currently approved indications of biologics and small molecules from the United States Food and Drug Administration for ankylosing spondylitis, psoriatic arthritis, juvenile idiopathic arthritis, and inflammatory bowel disease
Category | AS | PsA | JIA1 | UC | CD |
Biologics/TNFi | |||||
Etanercept | X | X | X | ||
Infliximab | X | X | X | X | |
Adalimumab | X | X | X | X | X |
Golimumab | X | X | X | X | |
Certolizumab pegol | X | X | X | ||
Biologics/IL-17i | |||||
Ixekizumab | X | X | |||
Secukinumab | X | X | X | ||
Biologics/IL-12/23i | |||||
Ustekinumab | X | X | X | X | |
Biologics/IL-23i | |||||
Guselkumab | X | ||||
Risankizumab | X | X | |||
Biologics/IL-1i | |||||
Canakinumab | X | ||||
Biologics/IL-6i | |||||
Tocilizumab | X | ||||
Biologics/anti-integrin mAb | |||||
Natalizumab | X | ||||
Vedolizumab | X | X | |||
Biologics/anti-CTLA-4 mAb | |||||
Abatacept | X | X | |||
Small molecules/JAKi | |||||
Tofacitinib | X | X | X | X | |
Upadacitinib | X | X | X | ||
Small molecules/PDE4i | |||||
Apremilast | X | ||||
Small molecules/S1PR modulator | X |
- Citation: Wang CR, Tsai HW. Seronegative spondyloarthropathy-associated inflammatory bowel disease. World J Gastroenterol 2023; 29(3): 450-468
- URL: https://www.wjgnet.com/1007-9327/full/v29/i3/450.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i3.450